Working with the media
This page highlights information which of specific interest to media professionals.
The page is kept updated with news, events and information for journalists with a professional interest in the development and availability of medicines in the European Union.
Featured information
Search all press releases
You can search for all press releases, public statements and news stories in the news archive using keywords in the title and date. For further information contact the press office.
Finding Committee and Working Group members
The Agency publishes the names and where available the CVs and Declarations of Interest of all Committee and Working parties and other group members.
Funding, budgets and key operating information
You can find out more on how we work including core management documents such as annual reports and work programmes and information on financial management.
Special topics
The Agency is developing Special topics pages which deal with topics and issues in which the European Medicines Agency is involved. Topics are regularly added to the section.
News for media professionals
-
22/05/2013
eSubmission Gateway or web client to become mandatory for all eCTD submissions through the centralised procedure in 2014
From 1 March 2014, the use of the eSubmission Gateway or web client will become mandatory for all electronic Common Technical Document (eCTD) submissions through the centralised procedure. ... Read more
-
17/05/2013
European Medicines Agency reiterates PRAC recommendation for Diane 35 and generics
Following the conclusion of the Pharmacovigilance Risk Assessment Committee (PRAC) that the benefits of Diane 35 and its generics outweigh the risks in a specific patient group, the French National Agency for the Safety of Medicine and Health Products (ANSM) unexpectedly announced today the decision to suspend the marketing authorisations of these medicines in France. ... Read more
-
17/05/2013
International Clinical Trials Day: 20 May 2013
The European Medicines Agency supports International Clinical Trials Day, which is taking place on Monday 20 May 2013. ... Read more
-
17/05/2013
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 14-16 May 2013
The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for ProZinc (insulin human) from Boehringer Ingelheim Vetmedica GmbH, for the treatment of diabetes mellitus in cats to achieve reduction of hyperglycaemia and improvement of associated clinical signs. ... Read more
-
17/05/2013
European Medicines Agency recommends first vaccine for foot-and-mouth disease for authorisation at EU level
The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) has recommended the marketing authorisation for Aftovaxpur DOE for use in response to outbreaks of foot-and-mouth disease (FMD). ... Read more
- See all News for media professionals
Events of interest
-
20/03/2013 - 21/03/2013
MB
Management Board meeting: 20-21 March 2013
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance. ... Read more
-
16/11/2012
EMA
European Medicines Agency workshop on multiplicity issues in clinical trials
The workshop's topics include usefulness and limitations of newly developed strategies to deal with multiplicity and multiplicity arising from interim decisions. Objectives are to discuss current standards and strategies to address multiplicity in clinical trials and to identify issues where guidance is missing so far. ... Read more
-
23/10/2013
CAT
CAT-Translational Centre for Regenerative Medicine Leipzig collaborative workshop - advanced-therapy medicinal products: from bench to bedside. Regulatory path for translation of research to commercial medicinal products
This workshop is organised by the Committee for Advanced Therapies (CAT) in cooperation with a learned society. It is bringing together industry, academia and regulators to discuss how to progress forward the development of advanced-therapy medicinal products. It addresses specific issues related to cell-based medicinal products including products combined with medical devices to defining the regulatory path for translation of research to commercial medicinal products. ... Read more
-
22/11/2012
EMA
Workshop on clinical-trial data and transparency
The European Medicines Agency has announced that it will proactively publish clinical-trial data and enable access to full data sets by interested parties. A number of practical and policy issues need to be addressed before complex data sets can be made available. This workshop is intended to elicit the views, interests, and concerns from a broad range of institutions, groups and individuals to help the Agency define the modalities of proactive access to clinical-trial data. Registration closed. ... Read more
-
25/10/2012 - 26/10/2012
EMA
Workshop on development of new antibacterial medicines
This workshop's aim is to discuss aspects of the development of antibacterial medicinal products, including those targeting multiple-drug-resistant pathogens and with narrow-action spectra and discussion on specific indications. Participation is invitation-based only. Webinar access to a limited number of registered users is possible: register by 24 October 12:00 UK time. ... Read more
- See all Events of interest
Information for:
Find information for...
Search for medicines
